The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
New Alzheimer's Biomarkers may Support Early Diagnosis
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
Frontiers | Alzheimer's disease: a mini-review for the clinician
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
